BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 12740761)

  • 1. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia.
    Irrthum A; Devriendt K; Chitayat D; Matthijs G; Glade C; Steijlen PM; Fryns JP; Van Steensel MA; Vikkula M
    Am J Hum Genet; 2003 Jun; 72(6):1470-8. PubMed ID: 12740761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further delineation of the SOX18-related Hypotrichosis, Lymphedema, Telangiectasia syndrome (HTLS).
    Valenzuela I; Fernández-Alvarez P; Plaja A; Ariceta G; Sabaté-Rotés A; García-Arumí E; Vendrell T; Tizzano E
    Eur J Med Genet; 2018 May; 61(5):269-272. PubMed ID: 29307792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel autosomal dominant mutation in SOX18 resulting in a fatal case of hypotrichosis-lymphedema-telangiectasia syndrome.
    Wangberg H; Wigby K; Jones MC
    Am J Med Genet A; 2018 Dec; 176(12):2824-2828. PubMed ID: 30549413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypotrichosis-lymphedema-telangiectasia-renal defect associated with a truncating mutation in the SOX18 gene.
    Moalem S; Brouillard P; Kuypers D; Legius E; Harvey E; Taylor G; Francois M; Vikkula M; Chitayat D
    Clin Genet; 2015 Apr; 87(4):378-82. PubMed ID: 24697860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aortic Dilatation Associated With a De Novo Mutation in the SOX18 Gene: Expanding the Clinical Spectrum of Hypotrichosis-Lymphedema-Telangiectasia Syndrome.
    Wünnemann F; Kokta V; Leclerc S; Thibeault M; McCuaig C; Hatami A; Stheneur C; Grenier JC; Awadalla P; Mitchell GA; Andelfinger G; Preuss C
    Can J Cardiol; 2016 Jan; 32(1):135.e1-7. PubMed ID: 26148450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular defects in a mouse model of hypotrichosis-lymphedema-telangiectasia syndrome indicate a role for SOX18 in blood vessel maturation.
    Downes M; François M; Ferguson C; Parton RG; Koopman P
    Hum Mol Genet; 2009 Aug; 18(15):2839-50. PubMed ID: 19429912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel SOX18 mutation uncovered in Jordanian patient with hypotrichosis-lymphedema-telangiectasia syndrome by Whole Exome Sequencing.
    Bastaki F; Mohamed M; Nair P; Saif F; Tawfiq N; Al-Ali MT; Brandau O; Hamzeh AR
    Mol Cell Probes; 2016 Feb; 30(1):18-21. PubMed ID: 26631803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypotrichosis-lymphedema-telangiectasia syndrome: Report of ileal atresia associated with a SOX18 de novo pathogenic variant and review of the phenotypic spectrum.
    Coulie R; Niyazov DM; Gambello MJ; Fastré E; Brouillard P; Vikkula M
    Am J Med Genet A; 2021 Jul; 185(7):2153-2159. PubMed ID: 33851505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arap3 is dysregulated in a mouse model of hypotrichosis-lymphedema-telangiectasia and regulates lymphatic vascular development.
    Kartopawiro J; Bower NI; Karnezis T; Kazenwadel J; Betterman KL; Lesieur E; Koltowska K; Astin J; Crosier P; Vermeren S; Achen MG; Stacker SA; Smith KA; Harvey NL; François M; Hogan BM
    Hum Mol Genet; 2014 Mar; 23(5):1286-97. PubMed ID: 24163130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding the clinical spectrum of SOX18-related Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome.
    Dailey C; Oshodi RB; Boull C; Aggarwal A
    Eur J Med Genet; 2022 Nov; 65(11):104607. PubMed ID: 36096470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dominant-negative SOX18 mutant disrupts multiple regulatory layers essential to transcription factor activity.
    McCann AJ; Lou J; Moustaqil M; Graus MS; Blum A; Fontaine F; Liu H; Luu W; Rudolffi-Soto P; Koopman P; Sierecki E; Gambin Y; Meunier FA; Liu Z; Hinde E; Francois M
    Nucleic Acids Res; 2021 Nov; 49(19):10931-10955. PubMed ID: 34570228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recessive primary congenital lymphoedema caused by a VEGFR3 mutation.
    Ghalamkarpour A; Holnthoner W; Saharinen P; Boon LM; Mulliken JB; Alitalo K; Vikkula M
    J Med Genet; 2009 Jun; 46(6):399-404. PubMed ID: 19289394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sox7 and Sox17 are strain-specific modifiers of the lymphangiogenic defects caused by Sox18 dysfunction in mice.
    Hosking B; François M; Wilhelm D; Orsenigo F; Caprini A; Svingen T; Tutt D; Davidson T; Browne C; Dejana E; Koopman P
    Development; 2009 Jul; 136(14):2385-91. PubMed ID: 19515696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The VCAM-1 gene that encodes the vascular cell adhesion molecule is a target of the Sry-related high mobility group box gene, Sox18.
    Hosking BM; Wang SC; Downes M; Koopman P; Muscat GE
    J Biol Chem; 2004 Feb; 279(7):5314-22. PubMed ID: 14634005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The establishment of a predictive mutational model of the forkhead domain through the analyses of FOXC2 missense mutations identified in patients with hereditary lymphedema with distichiasis.
    Berry FB; Tamimi Y; Carle MV; Lehmann OJ; Walter MA
    Hum Mol Genet; 2005 Sep; 14(18):2619-27. PubMed ID: 16081467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sox18 induces development of the lymphatic vasculature in mice.
    François M; Caprini A; Hosking B; Orsenigo F; Wilhelm D; Browne C; Paavonen K; Karnezis T; Shayan R; Downes M; Davidson T; Tutt D; Cheah KS; Stacker SA; Muscat GE; Achen MG; Dejana E; Koopman P
    Nature; 2008 Dec; 456(7222):643-7. PubMed ID: 18931657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome.
    Fang J; Dagenais SL; Erickson RP; Arlt MF; Glynn MW; Gorski JL; Seaver LH; Glover TW
    Am J Hum Genet; 2000 Dec; 67(6):1382-8. PubMed ID: 11078474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and functional analysis of the Sry-related HMG box gene, Sox18.
    Hosking BM; Wyeth JR; Pennisi DJ; Wang SC; Koopman P; Muscat GE
    Gene; 2001 Jan; 262(1-2):239-47. PubMed ID: 11179689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel 9-amino-acid transactivation domain in the C-terminal part of Sox18.
    Sandholzer J; Hoeth M; Piskacek M; Mayer H; de Martin R
    Biochem Biophys Res Commun; 2007 Aug; 360(2):370-4. PubMed ID: 17603017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel VEGFR3 mutation causes Milroy disease.
    Butler MG; Dagenais SL; Rockson SG; Glover TW
    Am J Med Genet A; 2007 Jun; 143A(11):1212-7. PubMed ID: 17458866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.